Both inflammatory factors and lipid metabolism regulators [such as PPARγ, sterol regulatory element-binding protein 1(SREBP1), and CCAAT/enhancer binding protein β (C/EBP β)] have been identified to result in acquired resistance in breast cancer[84-88]. This evidence concerns the gene SREBF1 and breast carcinoma.